Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
BIVI	BIOVIE INC	$8.52M	-82.20%	-73.20%	-89.33%	9,178.80%	0.17	7.25	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$3.25M	N/A	-257.40%	-1,047.35%	462.40%	-1.90	0.64	15.20%	-14,062.50%	-13,568.75%
LGVN	LONGEVERON INC	$10.94M	-138.40%	-108.50%	-201.01%	-1,125.00%	0.56	2.09	74.90%	-1,485.10%	-1,485.11%
CURX	CURANEX PHARMACEUTICALS INC	$7.82M	-33.30%	-31.10%	-8.96%	-48.10%	0.01	77.53	N/A	N/A	N/A
AEON	AEON BIOPHARMA INC	$13.02M	N/A	0.00%	-0.59%	0.00%	-1.44	0.90	N/A	N/A	N/A
INAB	IN8BIO INC	$9.22M	-145.50%	-107.40%	-137.13%	-231.40%	0.27	6.91	N/A	N/A	N/A
NTRB	NUTRIBAND INC	$52.96M	-501.80%	-429.50%	-166.83%	-3,295.90%	0.12	7.53	33.50%	-1,518.30%	-559.93%
IGC	IGC PHARMA INC	$23.22M	-96.40%	-72.60%	-78.33%	-188.00%	0.20	1.32	46.20%	-582.80%	-582.82%
BLRX	BIOLINERX LTD	$15.56M	-16.10%	-7.20%	9.58%	53.60%	1.04	2.09	50.70%	-23.40%	19.65%
DYAI	DYADIC INTERNATIONAL INC	$30.83M	-537.20%	-78.10%	-90.29%	-119.30%	3.48	2.85	31.50%	-219.90%	-205.87%
ESLA	ESTRELLA IMMUNOPHARMA INC	$54.76M	N/A	-446.70%	137.24%	246.60%	-1.36	0.15	N/A	N/A	N/A
TCRT	ALAUNOS THERAPEUTICS INC	$5.87M	-168.00%	-120.70%	-143.60%	-479.50%	0.33	2.92	100.00%	-100,625.00%	-100,625.00%
SGMO	SANGAMO THERAPEUTICS INC	$134.60M	-814.00%	-116.50%	-283.90%	-311.60%	13.20	0.88	100.00%	-331.30%	-332.63%
NCEL	NEWCELX LTD	$1.15M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
ADIL	ADIAL PHARMACEUTICALS INC	$2.99M	-197.70%	-153.70%	-178.73%	8,956.20%	0.26	4.34	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$4.57M	-362.10%	-175.30%	-252.13%	359.90%	0.68	2.47	N/A	N/A	N/A
NEUP	NEUPHORIA THERAPEUTICS INC	$21.56M	-53.20%	-36.10%	-44.30%	358.50%	1.19	2.72	100.00%	-60.50%	-62.89%
LIMN	LIMINATUS PHARMA INC	$49.80M	N/A	N/A	N/A	N/A	-1.82	0.42	N/A	N/A	N/A
IMRN	IMMURON LTD	$4.71M	-50.30%	-40.70%	-63.80%	-160.50%	0.26	5.09	71.00%	-60.00%	-59.88%
BRTX	BIORESTORATIVE THERAPIES INC	$9.23M	-233.30%	-137.90%	-574.11%	-328.40%	1.56	1.37	93.30%	-3,304.80%	-3,304.77%
CMMB	CHEMOMAB THERAPEUTICS LTD	$9.79M	-89.90%	-75.70%	-89.80%	-217.80%	0.10	10.49	N/A	N/A	N/A
LONA	LEONABIO INC	$18.06M	-107.10%	-89.90%	-138.45%	-509.90%	0.12	9.70	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$3.78M	-249.80%	-152.70%	-206.66%	-309.50%	0.50	3.78	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$14.02M	-60.10%	-42.90%	-43.58%	-52.50%	0.78	13.20	N/A	N/A	N/A
KLTO	KLOTHO NEUROSCIENCES INC	$17.41M	-201.60%	-171.30%	-75.16%	3,177.10%	0.02	83.69	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$2.80M	-130.10%	-107.10%	-131.74%	8,266.30%	0.20	5.82	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$2.81M	N/A	-80.10%	791.18%	-138.60%	-13.08	0.06	100.00%	-26,308.90%	-13,260.47%
LYRA	LYRA THERAPEUTICS INC	$3.23M	-1,032.80%	-60.20%	-96.21%	-75.80%	-11.10	2.43	100.00%	-5,491.20%	-5,488.67%
HOTH	HOTH THERAPEUTICS INC	$12.54M	-133.70%	-123.40%	-147.77%	-3,822.00%	0.12	8.81	N/A	N/A	N/A
MREO	MEREO BIOPHARMA GROUP PLC	$67.47M	-75.00%	-63.70%	-90.19%	3,290.60%	0.15	8.71	73.60%	-8,314.60%	-8,583.60%
MBIO	MUSTANG BIO INC	$5.74M	-75.30%	-16.50%	-23.53%	24.30%	0.98	2.05	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$51.49M	N/A	-180.10%	-807.47%	238.30%	-2.11	1.08	N/A	N/A	N/A
MOLN	MOLECULAR PARTNERS AG	$175.74M	-51.00%	-44.90%	-55.21%	-116.80%	0.17	9.28	N/A	N/A	N/A
FOLD	AMICUS THERAPEUTICS INC	$4.41B	-6.80%	-1.70%	7.71%	7.50%	2.77	2.99	89.80%	-2.30%	8.63%
GDTC	CYTOMED THERAPEUTICS LTD	$13.50M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$3.64M	-47.80%	-42.60%	-49.15%	-68.70%	0.13	7.98	N/A	N/A	N/A
MNOV	MEDICINOVA INC	$78.47M	-24.90%	-23.40%	-27.14%	-363.10%	0.08	9.87	10.20%	-4,656.60%	-4,654.50%
MANE	VERADERMICS INC	N/A	N/A	N/A	N/A	N/A	-0.06	3.29	N/A	N/A	N/A
ABVC	ABVC BIOPHARMA INC	$42.28M	-64.10%	-27.50%	-27.59%	-43.10%	0.55	0.63	100.00%	-515.90%	-507.22%
MLEC	MOOLEC SCIENCE SA	$3.91M	-40.70%	-13.90%	-5.94%	-12.60%	1.77	0.91	38.80%	-16.50%	-7.55%
BOLD	BOUNDLESS BIO INC	$25.97M	-47.50%	-33.10%	-39.37%	-29.70%	0.53	10.14	N/A	N/A	N/A
SXTP	60 DEGREES PHARMACEUTICALS INC	$4.40M	-225.80%	-149.90%	-177.30%	-780.20%	0.53	2.87	22.40%	-688.20%	-647.06%
DARE	DARE BIOSCIENCE INC	$24.15M	N/A	-82.70%	-183.21%	165.90%	9.76	1.18	-44.70%	30,568.80%	30,568.80%
SILO	SILO PHARMA INC	$4.08M	-107.00%	-77.10%	-89.35%	-366.70%	0.28	8.70	65.20%	-7,041.10%	-7,034.36%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.14B	-161.90%	-37.80%	-60.39%	-50.70%	3.56	1.54	90.90%	-296.80%	-277.82%
ICCC	IMMUCELL CORP	$56.45M	8.00%	5.10%	5.60%	4.60%	0.54	4.21	40.90%	8.40%	8.42%
RNA	AVIDITY BIOSCIENCES INC	$10.98B	-37.70%	-33.70%	-27.99%	-43.70%	0.13	11.57	100.00%	-2,634.60%	-2,634.59%
IOBT	IO BIOTECH INC	$25.18M	-465.40%	-180.60%	-407.32%	5,856.20%	42.86	2.01	N/A	N/A	N/A
BCAB	BIOATLA INC	$12.41M	N/A	-193.50%	3,116.91%	1,007.10%	-1.51	0.54	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$3.15M	-697.20%	-255.30%	-366.23%	1,274.20%	0.49	2.88	N/A	N/A	N/A
INTS	INTENSITY THERAPEUTICS INC	$20.96M	-370.90%	-214.60%	-160.57%	-7,289.40%	0.33	3.60	N/A	N/A	N/A
VTYX	VENTYX BIOSCIENCES INC	$996.17M	-48.10%	-43.90%	-53.25%	-50.70%	0.11	17.86	N/A	N/A	N/A
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$32.91M	-20,541.50%	-187.50%	-494.36%	222.10%	2.15	1.39	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$60.50M	N/A	N/A	N/A	N/A	-1.55	1.89	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$148.66M	-271.40%	-37.70%	-65.09%	-71.60%	17.07	2.21	100.00%	-364.40%	-327.14%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$0.00	-1,550.20%	-33.30%	-59.40%	-27.70%	0.51	0.71	-147.00%	-387.90%	-503.40%
RAPT	RAPT THERAPEUTICS INC	$1.60B	-61.80%	-54.70%	-69.33%	-107.60%	0.09	12.04	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$4.77M	-64.60%	-54.60%	-79.78%	1,819.80%	0.28	4.56	100.00%	-110.40%	-110.40%
XBIT	XBIOTECH INC	$72.26M	-16.70%	-15.90%	-17.02%	-134.50%	0.03	41.78	N/A	N/A	N/A
CLDI	CALIDI BIOTHERAPEUTICS INC	$6.18M	-597.30%	-194.70%	-221.67%	-752.50%	0.99	2.12	N/A	N/A	N/A
RNAZ	TRANSCODE THERAPEUTICS INC	$8.17M	-685.60%	-319.80%	-1,200.88%	3,205.40%	2.67	1.60	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$25.08M	-25.20%	-23.20%	-22.44%	-36.50%	0.07	14.74	100.00%	-2,102.40%	-2,102.37%
VRAX	VIRAX BIOLABS GROUP LTD	$1.49M	-80.90%	-74.50%	-111.60%	-259.10%	0.12	11.35	-1,517.30%	-189,001.70%	-199,931.82%
AZTR	AZITRA INC	$2.12M	-304.20%	-206.60%	-444.97%	-684.50%	0.89	1.24	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$7.74M	-370.50%	-50.80%	-67.86%	-133.70%	102.78	1.12	N/A	N/A	N/A
REVB	REVELATION BIOSCIENCES INC	$2.44M	-251.20%	-195.30%	-73.88%	573.50%	0.17	6.92	N/A	N/A	N/A
VIVS	VIVOSIM LABS INC	$5.95M	-28.90%	-19.80%	-27.18%	-179.80%	0.37	3.10	98.60%	-1,416.40%	-1,405.00%
PLUR	PLURI INC	$32.11M	N/A	-64.10%	-1,420.17%	-55.20%	-2.64	0.53	42.90%	-1,700.70%	-1,619.38%
TVGN	TEVOGEN BIO HOLDINGS INC	$54.64M	N/A	-771.10%	1,393.99%	-8,185.70%	-1.57	0.32	N/A	N/A	N/A
CDT	CDT EQUITY INC	$1.82M	-2,194.50%	-289.50%	-444.72%	-897.30%	1.00	1.66	N/A	N/A	N/A
GBIO	GENERATION BIO CO	$35.98M	-94.80%	-34.10%	-62.10%	-34.60%	1.41	4.44	100.00%	-410.10%	-410.13%
IMNN	IMUNON INC	$10.04M	-501.10%	-166.80%	-299.16%	239,282.00%	1.20	1.73	N/A	N/A	N/A
ATHE	ALTERITY THERAPEUTICS LTD	$64.44M	-43.20%	-37.20%	-28.43%	-222.50%	0.09	12.98	100.00%	-159.00%	-158.08%
BCDA	BIOCARDIA INC	$13.27M	-58,896.60%	-241.80%	-300.92%	714.20%	1.34	1.62	N/A	N/A	N/A
ITRM	ITERUM THERAPEUTICS PLC	$15.94M	N/A	-74.80%	-94.04%	-83.90%	-5.40	2.14	-146.40%	-6,913.10%	-6,287.18%
CASI	CASI PHARMACEUTICALS INC	$19.01M	N/A	-131.50%	321.20%	1,240.40%	-1.86	0.30	35.80%	-183.90%	-178.98%
PULM	PULMATRIX INC	$9.06M	-94.10%	-85.40%	-131.42%	1,844.30%	0.05	19.97	100.00%	-207,333.30%	-207,333.33%
FBLG	FIBROBIOLOGICS INC	$12.97M	-1,219.20%	-146.50%	-914.69%	-666.90%	68.95	0.78	N/A	N/A	N/A
CUE	CUE BIOPHARMA INC	$25.20M	-271.70%	-118.90%	-231.28%	-1,177.90%	1.39	1.66	100.00%	-530.70%	-525.10%
SPRC	SCISPARC LTD	$365.67k	396.50%	155.80%	13,168.14%	557.40%	-6.68	0.55	42.30%	1,312.80%	1,434.74%
KPRX	KIORA PHARMACEUTICALS INC	$7.91M	-36.40%	-25.80%	-25.98%	-37.60%	0.33	8.80	N/A	N/A	N/A
PRTC	PURETECH HEALTH PLC	$449.04M	14.70%	8.90%	10.48%	15.50%	0.49	8.49	100.00%	793.00%	840.87%
EXOZ	EXOZYMES INC	$88.15M	-104.50%	-79.50%	-134.61%	-294.80%	0.44	4.53	N/A	N/A	N/A
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$2.36M	-67.50%	-62.30%	-77.90%	-318.50%	0.08	17.39	100.00%	-41,516.30%	-41,417.25%
PSTV	PLUS THERAPEUTICS INC	$35.73M	N/A	-172.50%	-334.59%	276.00%	2.69	1.29	100.00%	-391.30%	-321.61%
CSBR	CHAMPIONS ONCOLOGY INC	$99.04M	57.50%	7.90%	29.37%	36.90%	6.22	0.96	50.10%	4.20%	4.03%
CELU	CELULARITY INC	$36.83M	N/A	-66.40%	-149.15%	-98.10%	-6.69	0.16	50.60%	-198.90%	-179.83%
VALN	VALNEVA SE	$770.57M	-58.90%	-21.50%	-24.13%	-19.10%	1.98	1.78	45.40%	-56.80%	-39.94%
EVGN	EVOGENE LTD	$9.41M	N/A	-8.20%	-4.31%	-6.20%	7.74	5.11	50.80%	-54.10%	-18.65%
ATNM	ACTINIUM PHARMACEUTICALS INC	$35.88M	-151.70%	-52.30%	-70.16%	1,172.70%	3.07	7.96	100.00%	-38,443.30%	-38,443.33%
PPCB	PROPANC BIOPHARMA INC	$2.54M	-601.00%	-421.20%	-434.79%	-535.70%	0.25	2.45	N/A	N/A	N/A
PPBT	PURPLE BIOTECH LTD	$54.84M	10.00%	8.90%	9.76%	-181.30%	0.19	1.78	N/A	N/A	N/A
SER	SERINA THERAPEUTICS INC	$25.27M	-1,259.20%	-213.60%	-511.98%	6,493.10%	6.15	1.31	100.00%	-16,022.40%	-15,994.83%
ADXN	ADDEX THERAPEUTICS LTD	$6.03M	-78.30%	-67.70%	-98.97%	-114.30%	0.23	2.01	100.00%	-3,845.80%	-3,843.07%
CYCN	CYCLERION THERAPEUTICS INC	$4.32M	-24.60%	-22.40%	-23.06%	-41.30%	0.09	5.78	100.00%	-77.00%	-77.02%
ANEB	ANEBULO PHARMACEUTICALS INC	$20.54M	-67.80%	-64.10%	-83.21%	7,349.80%	0.10	10.93	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$16.80M	-68.40%	-31.90%	-55.39%	105.10%	1.00	0.19	N/A	N/A	N/A
TOVX	THERIVA BIOLOGICS INC	$7.42M	-201.80%	-78.10%	-132.05%	-164.80%	3.58	0.90	N/A	N/A	N/A
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$4.98M	-88.90%	-85.20%	-106.61%	3,830.80%	0.05	20.71	60.00%	-99,356.80%	-99,356.80%
ABP	ABPRO HOLDINGS INC	$4.07M	N/A	-697.20%	68.47%	66.90%	-1.07	0.07	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #1 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 15, which is -9 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 5 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -26.92% over the past year, overperforming other biotech stocks by 4 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $21.86, an upside of 242.59% from Biocryst Pharmaceuticals's current stock price of $6.38.

Biocryst Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Biocryst Pharmaceuticals, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -8 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 37.84% over the past year, overperforming other biotech stocks by 69 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $213.27, an upside of 28.87% from Jazz Pharmaceuticals's current stock price of $165.50.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: B, Safety: C, Financials: C, and AI: B.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 33, which is 9 points higher than the biotech industry average of 24.

PHAR passed 10 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 81.4% over the past year, overperforming other biotech stocks by 112 percentage points.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 26.41%, which is 21 percentage points higher than the biotech industry average of 5.56%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.33%, which is 2 percentage points higher than the biotech industry average of 5.56%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.97%, which is -4 percentage points lower than the biotech industry average of 5.56%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and down -0.36% over the last week. Roivant Sciences was the among the top gainers in the biotechnology industry, gaining 22.14% yesterday.

Roivant Sciences shares are trading higher after the company reported better-than-expected Q3 sales results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the biotech industry average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -3.89% in the past year. It has overperformed other stocks in the biotech industry by 27 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Innoviva's stock has gained 19.39% in the past year. It has overperformed other stocks in the biotech industry by 50 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 44.62% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

64.15% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.9% over the next year.

3.35% of biotech stocks have a Zen Rating of A (Strong Buy), 6.5% of biotech stocks are rated B (Buy), 41.93% are rated C (Hold), 37.53% are rated D (Sell), and 10.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 234.95x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.